Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients

13 Jun 2018

Abstract excerpt

Background: The appearance and dissemination of MDR among pathogenic bacteria has forced the search for new antimicrobials. Bacteriocins have been proposed as potential alternatives for the treatment of infections due to multiresistant strains. Objectives: To analyse the activity of R-pyocins against clinical isolates of Pseudomonas aeruginosa from patients with cystic fibrosis and other sources and evaluate them...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial agents and applications
Share to Bacterial biofilms and quorum sensing
Share to Cystic Fibrosis Research Advances

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30052973
DOI: 10.1093/jac/dky261

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patientsPMID 30052973Read ↗

R pyocin sensitivity of Pseudomonas aeruginosa clinical isolates from different disease types.Semantic proximity Read ↗

Heterogenous susceptibility to R-pyocins in populations of <i>Pseudomonas aeruginosa</i> sourced from cystic fibrosis lungsSemantic proximity Read ↗

Competition in Biofilms between Cystic Fibrosis Isolates of Pseudomonas aeruginosa Is Shaped by R-PyocinsSemantic proximity Read ↗

Competition in biofilms between cystic fibrosis isolates of <i>Pseudomonas aeruginosa</i> is shaped by R-pyocinsSemantic proximity Read ↗

High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infectionsSemantic proximity Read ↗

New alternative therapeutic strategies against Pseudomonas aeruginosa, an opportunistic multi-resistant pathogen with a myriad of virulence factors.Semantic proximity Read ↗

High prevalence of lipopolysaccharide mutants and R2-Pyocin susceptible variants in <i>Pseudomonas aeruginosa</i> populations sourced from cystic fibrosis lung infectionsSemantic proximity Read ↗

Role of bacteriocins in mediating interactions of bacterial isolates taken from cystic fibrosis patientsSemantic proximity Read ↗

Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.Semantic proximity Read ↗

R-type pyocin is required for competitive growth advantage between Pseudomonas aeruginosa strains.Semantic proximity Read ↗

Role of R5 Pyocin in the Predominance of High-Risk <i>Pseudomonas aeruginosa</i> IsolatesSemantic proximity Read ↗

Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis StrainsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.